October 30, 2025 · Form 4 insider transaction
Gheuens Sarah sold 200 shares of Agios Pharmaceuticals, Inc. at $43.81 per share, a transaction worth $8.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.